Yabao Pharmaceutical Group Co Ltd (600351) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.047x

Based on the latest financial reports, Yabao Pharmaceutical Group Co Ltd (600351) has a cash flow conversion efficiency ratio of 0.047x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥129.49 Million ≈ $18.95 Million USD) by net assets (CN¥2.76 Billion ≈ $403.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Yabao Pharmaceutical Group Co Ltd balance sheet independence to measure how much of total assets are equity-financed.

Yabao Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2024)

This chart illustrates how Yabao Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 600351 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Yabao Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yabao Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Tamar Petroleum Ltd TA:TMRP	0.237x
Tai-Tech Advanced Electronics Co Ltd TWO:3357	0.022x
DAKOTA GOLD CORP. DL-001 F:RR6	-0.063x
FinVolution Group NYSE:FINV	0.052x
YaGuang Technology Group Co Ltd SHE:300123	-0.035x
Xiangpiaopiao Food Co Ltd SHG:603711	0.071x
Echoiq Ltd AU:EIQ	-0.300x
Pantoro Gold Ltd AU:PNR	0.225x

Annual Cash Flow Conversion Efficiency for Yabao Pharmaceutical Group Co Ltd (2001–2024)

The table below shows the annual cash flow conversion efficiency of Yabao Pharmaceutical Group Co Ltd from 2001 to 2024. For the full company profile with market capitalisation and key ratios, see Yabao Pharmaceutical Group Co Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.89 Billion ≈ $423.62 Million	CN¥471.69 Million ≈ $69.02 Million	0.163x	-1.98%
2023-12-31	CN¥2.99 Billion ≈ $438.01 Million	CN¥497.55 Million ≈ $72.81 Million	0.166x	+8.54%
2022-12-31	CN¥3.01 Billion ≈ $439.97 Million	CN¥460.46 Million ≈ $67.38 Million	0.153x	+3.74%
2021-12-31	CN¥2.96 Billion ≈ $433.67 Million	CN¥437.50 Million ≈ $64.02 Million	0.148x	+9.21%
2020-12-31	CN¥2.82 Billion ≈ $412.41 Million	CN¥380.96 Million ≈ $55.75 Million	0.135x	-13.38%
2019-12-31	CN¥2.72 Billion ≈ $398.67 Million	CN¥425.17 Million ≈ $62.22 Million	0.156x	+10.21%
2018-12-31	CN¥3.01 Billion ≈ $440.86 Million	CN¥426.60 Million ≈ $62.43 Million	0.142x	+155.17%
2017-12-31	CN¥2.91 Billion ≈ $426.47 Million	CN¥161.73 Million ≈ $23.67 Million	0.055x	-2.85%
2016-12-31	CN¥2.73 Billion ≈ $399.54 Million	CN¥155.95 Million ≈ $22.82 Million	0.057x	+6.62%
2015-12-31	CN¥2.68 Billion ≈ $391.88 Million	CN¥143.47 Million ≈ $20.99 Million	0.054x	-45.42%
2014-12-31	CN¥1.82 Billion ≈ $266.31 Million	CN¥178.63 Million ≈ $26.14 Million	0.098x	+193.10%
2013-12-31	CN¥1.70 Billion ≈ $248.21 Million	CN¥56.80 Million ≈ $8.31 Million	0.033x	+155.92%
2012-12-31	CN¥1.62 Billion ≈ $236.39 Million	CN¥-96.73 Million ≈ $-14.15 Million	-0.060x	-270.37%
2011-12-31	CN¥1.16 Billion ≈ $169.56 Million	CN¥40.73 Million ≈ $5.96 Million	0.035x	+89.80%
2010-12-31	CN¥1.00 Billion ≈ $146.71 Million	CN¥18.57 Million ≈ $2.72 Million	0.019x	-95.48%
2009-12-31	CN¥899.55 Million ≈ $131.63 Million	CN¥368.56 Million ≈ $53.93 Million	0.410x	+230.61%
2008-12-31	CN¥830.32 Million ≈ $121.50 Million	CN¥102.90 Million ≈ $15.06 Million	0.124x	-55.43%
2007-12-31	CN¥380.08 Million ≈ $55.62 Million	CN¥105.69 Million ≈ $15.47 Million	0.278x	+702.54%
2006-12-31	CN¥334.54 Million ≈ $48.95 Million	CN¥11.59 Million ≈ $1.70 Million	0.035x	-53.49%
2005-12-31	CN¥354.37 Million ≈ $51.86 Million	CN¥26.40 Million ≈ $3.86 Million	0.074x	-68.41%
2004-12-31	CN¥338.16 Million ≈ $49.48 Million	CN¥79.73 Million ≈ $11.67 Million	0.236x	+879.94%
2003-12-31	CN¥318.26 Million ≈ $46.57 Million	CN¥-9.62 Million ≈ $-1.41 Million	-0.030x	-134.57%
2002-12-31	CN¥277.81 Million ≈ $40.65 Million	CN¥24.29 Million ≈ $3.55 Million	0.087x	-65.96%
2001-12-31	CN¥91.84 Million ≈ $13.44 Million	CN¥23.59 Million ≈ $3.45 Million	0.257x	--

About Yabao Pharmaceutical Group Co Ltd

SHG:600351 China Drug Manufacturers - Specialty & Generic

Market Cap

$674.40 Million

CN¥4.61 Billion CNY

Market Cap Rank

#10735 Global

#2913 in China

Share Price

CN¥6.66

Change (1 day)

-1.48%

52-Week Range

CN¥5.70 - CN¥7.66

All Time High

CN¥14.53